drugset / Trial / NCT00625781

Treatment of Impaired Glucose Tolerance in Pregnancy

NCT00625781

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate if treatment (insulin or diet) of pregnant women with impaired glucose tolerance (75-g OGTT with a fasting P-gluc \<7.0 mmol/l and 2 h P-gluc \>10.0 and \<12.2 mmol/l) close to normoglycemia reduces children´s birth weight and neonatal morbidity. There will be a focus on treatment according to specific goals and separate follow-up regimes for the children and women post partum.

Timeline

Start
2008-02
Primary completion
2012-06
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin human (isophane) Unknown
Subject insulin aspart Protein / enzyme biologic